Thelium Therapeutics

Thelium is committed to the development of non-immunosuppressive small molecule therapies for treatment of inflammatory diseases.

Their world class team has 2 decades of intestinal epithelial barrier expertise combined with a track record of success spanning over 35 INDs and 6 commercial products.